These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7352586)

  • 21. Amantadine in Parkinson's disease.
    Lancet; 1969 Aug; 2(7616):364. PubMed ID: 4183981
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of amantadine in parkinsonism: clinical and neurophysiological findings].
    Fünfgeld EW
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1834-6. PubMed ID: 5453004
    [No Abstract]   [Full Text] [Related]  

  • 23. 'Cannabis-induced psychosis' may obscure paranoid schizophrenia.
    Saxena S
    Natl Med J India; 1993; 6(2):78-9. PubMed ID: 8477216
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment with L-dopa and amantadine in Parkinson's disease.
    Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
    Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 26. Amphetamine psychosis or paranoid schizophrenia?
    Zeidman H; Oscherwitz M; Addario D
    West J Med; 1975 May; 122(5):394-405. PubMed ID: 1130030
    [No Abstract]   [Full Text] [Related]  

  • 27. Amantadine and alpha-methyldopa: effects and interactions.
    Cohen MR
    Am J Psychiatry; 1979 Jun; 136(6):864-5. PubMed ID: 443493
    [No Abstract]   [Full Text] [Related]  

  • 28. The comparative value of amantadine and levodopa.
    Dallos V; Heathfield K; Stone P; Allen F
    Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 31. [Amantadine and the occurrence of livedo reticularis].
    Kalsbeek GL; Koopmans-van Dorp B
    Ned Tijdschr Geneeskd; 1974 Jan; 118(2):66-8. PubMed ID: 4825314
    [No Abstract]   [Full Text] [Related]  

  • 32. The antiparkinson properties of amantadine in drug-induced parkinsonism.
    Kelly JT; Abuzzahab FS
    J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 34. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 36. [Amantadine-induced livedo reticularis].
    Löffler H; Habermann B; Effendy I
    Hautarzt; 1998 Mar; 49(3):224-7. PubMed ID: 9565792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial of amantadine in Parkinson's disease.
    Campbell AM; Williams MJ
    Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
    [No Abstract]   [Full Text] [Related]  

  • 38. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 39. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amantadine in the treatment of Parkinson's disease].
    Penders C
    Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.